Psychotic symptoms in Alzheimer disease: evidence for a distinct phenotype.
Though efforts to identify the genetic etiology of Alzheimer disease (AD) have made substantial progress, to date only some of the genes contributing to AD risk have been identified. Utilization of more etiologically homogeneous subphenotypes represents one strategy to facilitate the identification of novel risk genes in complex disorders. In this review, we evaluate the hypothesis that psychotic symptoms, such as delusions and hallucinations, define a suitable subphenotype in AD patients for gene-mapping efforts. Psychotic symptoms occur in 40-60% of patients with AD and are associated with more severe cognitive deficits and a more rapidly deteriorating course. The presence of psychotic symptoms in AD confers increased risk of similar symptoms to affected siblings. Candidate gene association analyses and initial linkage analysis have yielded significant results. We discuss possible genetic models of psychotic symptoms in AD, and suggest strategies for further investigation. Identification of such genetic factors may facilitate gene-mapping studies for both AD and idiopathic psychoses.
Sweet
R A
RA
Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA 15231, USA. sweetra@msx.upmc.edu
Nimgaonkar
V L
VL
Devlin
B
B
Jeste
D V
DV
D000544:Alzheimer Disease / Q000235:genetics* / Q000523:psychology; D006801:Humans; D010641:Phenotype; D011618:Psychotic Disorders / Q000523:psychology*